Preparation of brain targeted immunoliposomes

Yaoxue Xuebao

Volumn 44, Issue 11, 2009, Pages 1285-1290

  Zhao, Hao ^a   Wang, Ren Zhi ^a   Wang, Fei ^b   Zhang, Yan Hui ^b   Chen, Xing Wei ^b   Li, Xin Ru ^b   Liu, Yan ^b   Li, Gui Lin ^a   Wei, Jun Ji ^a   Feng, Ming ^a   Kong, Yan Guo ^a   Li, Shi Fang ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Blood brain barrier; Immunoliposome; Non viral vector

Indexed keywords

BETA GALACTOSIDASE; CHOLESTEROL; DICHLOROMETHANE; IMMUNOLIPOSOME; OIL; PHOSPHOLIPID; TREHALOSE; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN DISEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE VECTOR; NONHUMAN; NONVIRAL GENE THERAPY; RAT; ROOM TEMPERATURE; ULTRASOUND; VEIN; WATER VAPOR;

ANIMALS; ANTIBODIES, MONOCLONAL; BETA-GALACTOSIDASE; BLOOD-BRAIN BARRIER; BRAIN; DRUG DELIVERY SYSTEMS; GENETIC VECTORS; LAC OPERON; LIPOSOMES; MALE; PARTICLE SIZE; PLASMIDS; POLYETHYLENE GLYCOLS; RATS; RECEPTORS, TRANSFERRIN; TISSUE DISTRIBUTION;

EID: 76049123929     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zhang Y, Calon F, Zhu C, et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism [J]. Hum Gene Ther, 2003, 14: 1-12.
2. Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes [J]. NeuroRx, 2005, 2: 99-107.
3. Monnard PA, Oberholzer T, Luisi P, et al. Entrapment of nucleic acids in liposomes [J]. Biochim Biophys Acta, 1997, 1329: 39-50.
4. Kim NH, Park HM, Chung SY, et al. Immunoliposomes carrying plasmid DNA: preparation and characterization [J]. Arch Pharm Res, 2004, 27: 1263-1269.
5. Thomas CE, Ehrhardt A, Kay MA, et al. Progress and problems with the use of viral vectors for gene therapy [J]. Nat Rev Genet, 2003, 4: 346-358.
6. Schnell MA, Zhang Y, Tazelaar J, et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors [J]. Mol Ther, 2001, 3 (5 Pt 1): 708-722.
7. Smyth Templeton N. Liposomal delivery of nucleic acids in vivo [J]. DNA Cell Biol, 2002, 21: 857-867.
8. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream [J]. Science, 2004, 303:1818-1822.
9. Zhang Y, Jeong Lee H, Boado RJ, et al. Receptor-mediated delivery of an antisense gene to human brain cancer cells [J]. J Gene Med, 2002, 4: 183-194.
10. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies [J]. Clin Pharmacokinet, 2003, 42: 419-436.
11. Cullis PR, Chonn A, Semple SC. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo [J]. Adv Drug Deliv Rev, 1998, 32: 3-17.
12. Maruyama K, Ishida O, Takizawa T, et al. Possibility of active targeting to tumor tissues with liposomes [J]. Adv Drug Deliv Rev, 1999, 40: 89-102.
13. Klibanov AL, Maruyama K, Torchilin VP, et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes [J]. FEBS Lett, 1990, 268: 235-237.
14. Gosk T, Vermehren C, Storm G, et al. Targeting anti-transferrin receptor antibody (0X26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion [J]. J Cerebral Blood Flow Metab, 2004, 24: 1193-1204.
15. Lasic DD, Ceh B, Stuart MC, et al. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery [J]. Biochim Biophys Acta, 1995, 1239: 145-156.